Tuberculosis: Causes, Epidemiology, and Treatment
This paper provides a comprehensive overview of tuberculosis (TB), an infectious disease caused by the bacterium Mycobacterium tuberculosis. It examines the microbiological characteristics of the pathogen, including its unique cell wall composition and immune-evasion mechanisms. The paper traces the historical record of TB from ancient civilizations through its peak in 18th-century Europe. It then surveys global epidemiology, pathological progression, and the host immune response. Finally, it outlines standard multi-drug treatment protocols, vaccination strategies, and socioeconomic and political factors that influence disease prevention and public health policy.
- Causative Agent: Biology and immune-evasion of M. tuberculosis
- History of Tuberculosis: Ancient origins through 18th-century epidemic
- Epidemiology: Global distribution, incidence rates, and transmission
- Pathology: Infection sites, spread, and symptoms
- Response and Treatment: Immune response, drug regimens, and prevention
- Socioeconomic and Political Considerations: Stigma, policy, and mandatory screening proposals
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper moves logically from microbiology to history to public health, giving readers a well-rounded understanding of TB without assuming prior knowledge.
- It integrates specific scientific detail — such as the UreC gene, isotuberculosinol production, and the 4-drug treatment regimen — alongside accessible explanations, balancing rigor with readability.
- The inclusion of a socioeconomic section broadens the analysis beyond pure science, acknowledging how stigma and policy affect real-world disease control.
Key academic technique demonstrated
The paper demonstrates effective use of a thematic organizational structure: each section addresses a distinct dimension of the disease (biological, historical, epidemiological, clinical, and social), allowing evidence from multiple cited sources to be integrated without overlap. This compartmentalized approach is a useful model for writing survey-style science papers.
Structure breakdown
The paper opens with the microbiology of the causative agent, then moves historically before addressing global epidemiology. It next covers pathological progression and the host immune response, followed by a detailed treatment and prevention section. A final brief section addresses socioeconomic and political dimensions. References follow APA format throughout.
Causative Agent
Tuberculosis is an infectious disease of animals and humans. The most common causative agent of the disease is a bacterium — a mycobacterium — known as Mycobacterium tuberculosis. This bacterium was first discovered by Robert Koch in 1882. The physiology of this bacterium is aerobic, and it therefore requires very high oxygen levels. It is primarily a pathogen of the mammalian respiratory system and infects the lungs. The most common methods used to diagnose tuberculosis are acid-fast staining, the tuberculin skin test, and chest radiography.
M. tuberculosis requires oxygen in order to grow. Due to the presence of mycolic acid, M. tuberculosis has an unusual waxy coating on its surface that makes the cells impervious to Gram staining. It cannot retain any bacteriological stain as a result of the high lipid content in its cell wall; therefore, acid-fast staining (also known as Ziehl-Neelsen staining) is used instead. Despite this, M. tuberculosis is still considered to be a Gram-positive bacterium. While mycobacteria do not fit the Gram-positive category from a strictly empirical standpoint, they can be classified as acid-fast Gram-positive bacteria because they lack an outer membrane.
M. tuberculosis divides once every 15–20 hours, which is relatively slow compared to other bacteria that divide in minutes. It is a small bacillus, and as a result it is able to withstand weak disinfectants and can survive for weeks in a dry state. The mycolic acid found in its cell wall contributes to this resistance and is a key virulence factor. When the bacteria are in the lungs, they are taken up by alveolar macrophages, but those macrophages are unable to digest and eliminate the bacterium. The cell wall of the bacteria prevents fusion between the phagosome and the lysosome, which contains various antimycobacterial factors. M. tuberculosis blocks the bridging molecule, but this blockage does not prevent the fusion of vesicles filled with nutrients, allowing the bacteria to multiply unchecked within the macrophage. M. tuberculosis also carries the UreC gene, which prevents phagosome acidification, and it produces isotuberculosinol, which prevents phagosome maturation. The bacterium is also able to evade macrophage killing by neutralizing reactive nitrogen intermediaries.
References
Mandal, A. (2014). History of tuberculosis. Retrieved October 17, 2014, from http://www.news-medical.net/health/History-of-Tuberculosis.aspx
Knechel, N. (2009). Tuberculosis: Pathophysiology, clinical features, and diagnosis. Retrieved October 17, 2014, from http://ccn.aacnjournals.org/content/29/2/34.short
Mathema, B., Kurepina, N., Bifani, P., & Kreiswirth, B. (2006). Molecular epidemiology of tuberculosis: Current insights. Retrieved October 18, 2014, from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592690/
Create your account
Always verify citation format against your institution’s current style guide requirements.